Clinical Trial Update: Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Lexiscan for myocardial stress perfusion CT using a 3rd generation dual-source CT system; completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Artery Disease

Drugs mentioned

• Lexiscan (regadenoson)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Cardiovascular Diseases, Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-08-09